Pretomanid
Pretomanid is a nitroimidazooxazine antimycobacterial agent that is activated by the deazaflavin-dependent nitroreductase (Ddn) of Mycobacterium tuberculosis, producing reactive nitrogen and carbon-based radicals that inhibit mycolic acid biosynthesis and cause cell death under both aerobic and anaerobic conditions. It is used in combination with bedaquiline and linezolid for the treatment of extensively drug-resistant (XDR) and treatment-intolerant or non-responsive multidrug-resistant tuberculosis.
Peso Molecular
359,2600 g/mol
LogP
2,80
TPSA
91,30 Ų
Regra dos 5 de Lipinski
Aprovado
Áreas Terapêuticas
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Estrutura 2D
Cite this structure
Embed this structure
SMILES
O=[N+]([O-])c1cn2c(n1)OC[C@@H](OCc1ccc(OC(F)(F)F)cc1)C2
InChI
InChI=1S/C14H12F3N3O5/c15-14(16,17)25-10-3-1-9(2-4-10)7-23-11-5-19-6-12(20(21)22)18-13(19)24-8-11/h1-4,6,11H,5,7-8H2/t11-/m0/s1
Molecular Formula
C14H12F3N3O5
HBD / HBA
- / 9
Ligações Rotacionáveis
4
Átomos Pesados
25
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Perguntas frequentes
Pretomanid is a nitroimidazooxazine antimycobacterial agent that is activated by the deazaflavin-dependent nitroreductase (Ddn) of Mycobacterium tuberculosis, producing reactive nitrogen and carbon-based radicals that inhibit mycolic acid biosynthesis and cause cell death under both aerobic and anaerobic conditions. It is used in combination with bedaquiline and linezolid for the treatment of extensively drug-resistant (XDR) and treatment-intolerant or non-responsive multidrug-resistant tuberculosis.
Yes, Pretomanid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL227875. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 456199. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="pretomanid"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/pretomanid/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/pretomanid/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/pretomanid/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="pretomanid"></drugfyi-drug>